Inhaler technique mastery and maintenance in healthcare professionals trained on different devices

Bosnic‐Anticevich, Sinthia; Callan, Christina; Chrystyn, Henry; Lavorini, Federico; Nikolaou, Vasilis; Kritikos, Vicky; Dekhuijzen, P.N.R.; Roche, N.; Bjermer, Leif; Rańd, Cynthia S.; Zwar, Nicholas; Price, David

doi:10.1080/02770903.2017.1310227

Cited by 21 publications

(24 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared with other inhalers, the Spiromax device is ready for actuation after the single step of opening the cap and, therefore, has the theoretical advantage of being more intuitive and easier to use. Moreover, B/F Spiromax is easy for healthcare professionals to learn how to use correctly [35], which may reduce time involved in patient education and training [34]. Thus, a possible reason for the symptomatic improvements observed with B/F Spiromax in our study was that patients were more likely to be using the inhaler correctly, thereby maximizing drug delivery.…”

Section: Discussionmentioning

confidence: 78%

Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial

et al. 2018

View full text Add to dashboard Cite

Background: The fixed-dose combination of budesonide/formoterol (B/F) has been available in the Spiromax® dry powder inhaler since 2014. Objectives: To assess patient satisfaction, inhaler use errors, and disease control in patients with asthma or chronic obstructive pulmonary disease (COPD) treated with B/F Spiromax. Methods: This non-interventional, prospective, 12-week study enrolled consecutive asthma or COPD patients who had recently begun treatment with B/F Spiromax or were switched from another inhaled corticosteroid/long-acting β₂-agonist combination to B/F Spiromax in routine clinical practice. Patients recruited from 243 specialist respiratory clinics or general practices in Germany were assessed for patient satisfaction (Satisfaction with Inhalers and Preference questionnaire), inhaler application errors (modified Easy Low Instruction over Time checklist), disease control, and safety. Results: The population included 3,943 patients: asthma n = 2,707 (68.7%); COPD n = 1,236 (31.3%). At baseline, 60.1% of patients were “satisfied” or “very satisfied” with their previous inhaler, and this increased to 88.8% at week 12 of B/F Spiromax use. Overall, 62.1% of pre-treated patients preferred B/F Spiromax to their old inhaler. The frequency of any handling error observed with B/F Spiromax at week 12 was lower than at baseline (11.9 vs. 25.5% of patients, respectively). After 12 weeks, 77.4% were assessed as having improved (minimally, much, or very much) overall health status versus baseline. Guideline-defined disease severity (as rated by physicians) and patient-reported symptom severity improved during the study in both asthma and COPD patients. B/F Spiromax was well tolerated. Conclusion: B/F Spiromax was associated with high patient satisfaction, low device handling error rate, and improvements in clinical outcomes in real-world clinical practice.

show abstract

Section: Discussionmentioning

confidence: 78%

Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Many of the newer devices are reported to be easier to use [114][115][116][117]. However, it is still unknown what this means for both health care professionals (HCPs) and patients.…”

Section: Clinical and Device Preference Comparisons Of New Versus Oldmentioning

confidence: 99%

“…Next generation inhalers, that increase patient ease-of-use, have been developed to enhance the delivery of drugs to the bronchial tree and to improve the inhalation technique by reducing the possibility of making errors while operating the device. Inhaler devices such as the ELLIPTA ® and the NEXThaler ® were both found to reduce critical errors compared to other MDI and DPI inhalers [114][115][116][117].…”

Section: Clinical and Device Preference Comparisons Of New Versus Oldmentioning

confidence: 99%

Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD

Donner

Amaducci

Bacci

et al. 2018

Monaldi Arch Chest Dis

Self Cite

View full text Add to dashboard Cite

show abstract

“…Numerous studies have focused on the importance of proper training for an inhaler use [18][19][20] . Few have examined the additional impact of age, obesity and limited parental health literacy [21][22][23] .…”

Section: Discussionmentioning

confidence: 99%

Impact of educational intervention for correct inhaler technique on the quality of life of children with asthma

et al. 2020

View full text Add to dashboard Cite

Background/Aim. Asthma is the most common chronic disease in children and adolescents and has shown an apparent increase in incidence in recent years. The first purpose of the study was to evaluate the influence of education about proper use of inhalers on quality of life in children with asthma. Secondly, we aimed to understand which aspects of quality of life in children with asthma can be significantly improved after education and to identify factors that may affect the level of that improvement. Methods. In this prospective, before-and-after interventional study, a total of 147 children with asthma were enrolled. The Pediatric Asthma Quality of Life Questionnaire (PAQLQ) was used to measure the functional problems that are most troublesome to children with asthma. We used the Asthma Control Test (ACT), based on a series of question about symptoms and daily functioning, to identify patients with poorly controlled asthma. Forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF) were also determined. Trained educators estimated patients' inhaler technique and collected questionnaire information. Results. Multivariate analysis of covariance indicated significant differences between PAQLQ and ACT scores which all were significantly higher after education about proper use of inhalers (p < 0.001). A number of children demonstrating a correct inhalation technique improved from 28 (19%) to 127 (86.4%) (p < 0.001). Asthma severity accounted for the largest proportion of variability PAQLQ and ACT scores (38.4%). Conclusion. Inhaler technique improvement contributes to better asthma control in children with asthma rather than to their quality of life. Asthma severity proved to be a major contributor to variations in PAQLQ and ACT scores and significant obstacle for quality of life improvement in children with asthma.

show abstract

Inhaler technique mastery and maintenance in healthcare professionals trained on different devices

Abstract: There are significant differences in the nature and extent of training required to achieve and maintain mastery for Spiromax® and Turbuhaler® devices. The implications on clinical practice, device education delivery, and patient outcomes require further evaluation.

Cited by 21 publications

References 22 publications

Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial

Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial

Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD

Impact of educational intervention for correct inhaler technique on the quality of life of children with asthma

Contact Info

Product

Resources

About